Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations

Mostrar otras versiones (1)

The β(−)-particle-emitting erbium-169 is a potential radionuclide toward therapy of metastasized cancer diseases. It can be produced in nuclear research reactors, irradiating isotopically-enriched (168)Er(2)O(3). This path, however, is not suitable for receptor-targeted radionuclide therapy, where h...

Descripción completa

Detalles Bibliográficos
Autores principales: Talip, Zeynep, Borgna, Francesca, Müller, Cristina, Ulrich, Jiri, Duchemin, Charlotte, Ramos, Joao P., Stora, Thierry, Köster, Ulli, Nedjadi, Youcef, Gadelshin, Vadim, Fedosseev, Valentin N., Juget, Frederic, Bailat, Claude, Fankhauser, Adelheid, Wilkins, Shane G., Lambert, Laura, Marsh, Bruce, Fedorov, Dmitry, Chevallay, Eric, Fernier, Pascal, Schibli, Roger, van der Meulen, Nicholas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100037/
https://www.ncbi.nlm.nih.gov/pubmed/33968955
http://dx.doi.org/10.3389/fmed.2021.643175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100037/
https://www.ncbi.nlm.nih.gov/pubmed/33968955
http://dx.doi.org/10.3389/fmed.2021.643175

Ejemplares similares